SAN DIEGO, July 15 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that E.J. Brandreth has joined the company as Vice President of Quality and Regulatory. In this role, Mr. Brandreth will be responsible for leading Althea's quality and compliance programs, while overseeing the regulatory support activities, which are required to facilitate the launch of commercial manufacturing services.
(Photo: http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)
"We are very excited to welcome E.J. Brandreth to Althea. The diverse experience he brings to the company is particularly valuable, as it spans everything from clinical development of innovative products, to the preparation and validation required for commercial launch of successful biopharmaceuticals. His background in clinical and commercial biological products is a perfect fit for the expanding scope of projects at Althea," stated Dr. Magda Marquet, President and Co-CEO of Althea Technologies.
Mr. Brandreth brings over fifteen years of experience in the regulatory
and quality assurance fields for the biotechnology and pharmaceutical
industries. Prior to joining Althea Technologies, he was Vice President of
Quality at Favrille, Inc., where he had oversight of Quality Control,
Quality Assurance, Validation and Metrology. In the course of his career he
has managed the validation of 11 different biotechnology facilities, and
led the Process Validation Programs for five CBER/EMEA product launches.
Previous to Favrille, Mr. Brandreth was Senior Director of QA at BioMarin
Pharmaceuticals, Inc. where he supported a variety of clinical products and
launched two commercial products. Prior to that, he held management
positions in QA, Validation and Regulatory Affairs at IDEC Pharmaceuticals,
where h
'/>"/>
| SOURCE Althea Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |